Cargando…

Prime Time for HLA Desensitization: Imlifidase in the Spotlight

Detalles Bibliográficos
Autores principales:	Bestard, Oriol, Moreso, Francesc, Dorling, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Health Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348404/ https://www.ncbi.nlm.nih.gov/pubmed/37456683 http://dx.doi.org/10.3389/ti.2023.11616

Ejemplares similares

Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines
por: Couzi, Lionel, et al.
Publicado: (2023)

European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group
por: Mamode, Nizam, et al.
Publicado: (2022)

A Novel Daratumumab-Based Regimen for Desensitization in Highly HLA-Presensitized Patients Awaiting Kidney Transplantation
por: Zhao, Daqiang, et al.
Publicado: (2023)

Outcomes at 3 years posttransplant in imlifidase‐desensitized kidney transplant patients
por: Kjellman, Christian, et al.
Publicado: (2021)

Corrigendum: Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2023)

Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2022)

Immunoadsorption-Based HLA Desensitization in Patients Awaiting Deceased Donor Kidney Transplantation: An Interventional, Non-Randomised, Single Cohort Study
por: Bureau, Côme, et al.
Publicado: (2023)

Desensitization using imlifidase and EndoS enables chimerism induction in allosensitized recipient mice
por: Lin, Jiaxin, et al.
Publicado: (2020)

Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?
por: Bestard, Oriol, et al.
Publicado: (2023)

Imlifidase for the treatment of anti‐HLA antibody‐mediated processes in kidney transplantation
por: Huang, Edmund, et al.
Publicado: (2021)

Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)
por: Jordan, Stanley C., et al.
Publicado: (2021)

Alloimmune Risk Stratification for Kidney Transplant Rejection
por: Bestard, Oriol, et al.
Publicado: (2022)

Relevance of HLA-DP/DQ and INF-λ4 Polymorphisms to COVID-19 Outcomes
por: Ghazy, Amany A., et al.
Publicado: (2023)

Dynamic Behaviour of Donor Specific Antibodies in the Early Period Following HLA Incompatible Kidney Transplantation
por: Phillpott, Mason, et al.
Publicado: (2022)

Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti‐HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients
por: Lorant, Tomas, et al.
Publicado: (2018)

Chronic Pancreas Allograft Rejection Followed by Successful HLA-Incompatible Islet Alloautotransplantation: A Novel Strategy?
por: Veltkamp, Denise M. J., et al.
Publicado: (2023)

Complement-Binding Donor-Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney Transplantation Recipients
por: Sigurjonsdottir, Vaka K., et al.
Publicado: (2022)

The Clinical Impact of Anti-HLA Donor Specific Antibody Detection Through First Year Screening on Stable Kidney Transplant Recipients
por: Sharma, Akhil, et al.
Publicado: (2022)

The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice
por: van den Broek, Dennis A. J., et al.
Publicado: (2023)

Imlifidase-generated Single-cleaved IgG: Implications for Transplantation
por: Bockermann, Robert, et al.
Publicado: (2021)

Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients
por: Schimpf, Judith, et al.
Publicado: (2022)

Kidney Transplantation in Patients With Active SARS-CoV-2 Replication: An Initial Case Series
por: Halfon, Matthieu, et al.
Publicado: (2022)

Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
por: Papadimitriou-Olivgeris, Matthaios, et al.
Publicado: (2022)

Editorial: Equity in Transplantation: A Commitment for Progress in Troubled Times
por: Berney, Thierry, et al.
Publicado: (2022)

Timing of Early Salvage Therapy for Patients With Biochemical Relapse of Prostate Carcinoma
por: Argalácsová, Soňa, et al.
Publicado: (2023)

Association of Procurement Time With Pancreas Transplant Outcomes in Brain-Dead Donors
por: Eerola, Verner, et al.
Publicado: (2023)

Prolonged Organ Extraction Time Negatively Impacts Kidney Transplantation Outcome
por: Maassen, Hanno, et al.
Publicado: (2022)

ABO-Incompatibility: Time to Challenge the Paradigm of Equivalence in Live-Donor Kidney Transplantation?
por: Eskandary, Farsad, et al.
Publicado: (2022)

Islets-on-Chip: A Tool for Real-Time Assessment of Islet Function Prior to Transplantation
por: Raoux, Matthieu, et al.
Publicado: (2023)

The Effect of Language on Access to Timely COVID-19 Vaccination of Solid Abdominal Organ Transplant Recipients
por: de Crescenzo, Claire M., et al.
Publicado: (2023)

Modeling the Potential of Treg-Based Therapies for Transplant Rejection: Effect of Dose, Timing, and Accumulation Site
por: Lapp, Maya M., et al.
Publicado: (2022)

Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid Biopsy
por: Verhoeven, Jeroen G. H. P., et al.
Publicado: (2022)

Timing of Organ Procurement From Brain-Dead Donors Associates With Short- and Long-Term Outcomes After Liver Transplantation
por: Eerola, Verner, et al.
Publicado: (2022)

Using Information Available at the Time of Donor Offer to Predict Kidney Transplant Survival Outcomes: A Systematic Review of Prediction Models
por: Riley, Stephanie, et al.
Publicado: (2022)

Biomedical Science and New Frontiers
por: Rhodes, Anthony
Publicado: (2022)

The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time
por: Piemonti, Lorenzo, et al.
Publicado: (2023)

Age at Time of Kidney Transplantation as a Predictor for Mortality, Graft Loss and Self-Rated Health Status: Results From the Swiss Transplant Cohort Study
por: Beerli, Nadine, et al.
Publicado: (2022)

Lung Transplantation From Controlled and Uncontrolled Donation After Circulatory Death (DCD) Donors With Long Ischemic Times Managed by Simple Normothermic Ventilation and Ex-Vivo Lung Perfusion Assessment
por: Palleschi, Alessandro, et al.
Publicado: (2023)

Normothermic Regional Perfusion and Hypothermic Oxygenated Machine Perfusion for Livers Donated After Controlled Circulatory Death With Prolonged Warm Ischemia Time: A Matched Comparison With Livers From Brain-Dead Donors
por: Patrono, Damiano, et al.
Publicado: (2022)

CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer
por: Liau, Xiew Leng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_859gpanrpk0dkdr84taeo6iafl